CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-05 | EMSTER KURT VON Director | Sale | −920 | $12.51 | $12K | 18,316 |
| 2018-06-05 | EMSTER KURT VON Director | Option exercise · Warrant (right to buy) | −2,000 | 0 | ||
| 2018-06-04 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −741 | $67.13 | $50K | 147,819 |
| 2018-06-01 | Kulkarni Samarth Chief Executive Officer | Option exercise | +15,000 | $1.81 | $27K | 163,560 |
| 2018-06-01 | Kulkarni Samarth Chief Executive Officer | Sale | −4,600 | $67.28 | $309K | 158,960 |
| 2018-06-01 | Kulkarni Samarth Chief Executive Officer | Sale | −10,400 | $70.28 | $731K | 148,560 |
| 2018-06-01 | Kulkarni Samarth Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −15,000 | 264,558 | ||
| 2018-05-17 | Novak Rodger President | Option exercise | +35,240 | $1.81 | $64K | 1,183,247 |
| 2018-05-17 | Novak Rodger President | Option exercise | +39,760 | $14.00 | $557K | 1,223,007 |
| 2018-05-17 | Novak Rodger President | Sale | −75,000 | $60.00 | $4.5M | 1,148,007 |
| 2018-05-17 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −35,240 | 5,586 | ||
| 2018-05-17 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −39,760 | 160,240 | ||
| 2018-05-15 | Bolzon Bradley J PhD Director | Sale | −43,000 | $57.97 | $2.5M | 641,014 |
| 2018-05-15 | Bolzon Bradley J PhD Director | Sale | −1,000 | $58.73 | $59K | 640,014 |
| 2018-05-15 | Woiwode Thomas Director | Sale | −43,000 | $57.97 | $2.5M | 641,014 |
| 2018-05-15 | Woiwode Thomas Director | Sale | −1,000 | $58.73 | $59K | 640,014 |
| 2018-05-14 | Behbahani Ali Director | Other acquisition | +199 | 199 | ||
| 2018-05-14 | EMSTER KURT VON Director | Sale | −116,247 | $56.90 | $6.6M | 1,520,955 |
| 2018-05-14 | EMSTER KURT VON Director | Sale | −73,144 | $55.72 | $4.1M | 1,447,811 |
| 2018-05-14 | EMSTER KURT VON Director | Sale | −126,901 | $54.99 | $7.0M | 1,320,910 |
Page 50 of 62 · 1,221 trades